Spots Global Cancer Trial Database for aromatase inhibitor treatment
Every month we try and update this database with for aromatase inhibitor treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
